According to a study published last year, the amino-acid-based elemental formula, known as Neocate, can lead to a series of nasty side-effects. If your child has taken Neocate and is suffering from rickets, Hypophosphatemia or inexplicable bone … [Read more...]
Limbrel Linked to Life-Threatening Medical Conditions
Last November, the FDA asked Primus Pharmaceuticals to withdraw its product, Limbrel, from the market, due to adverse-event reports indicating potential damage to the liver and inflammation of the alveoli in the lungs. The company failed to respond … [Read more...]
The Issue With Viberzi
After the FDA released a notice on March 15th 2017, it became clear that patients without a gallbladder should steer clear of the IBS medicine, Viberzi. The drug, when taken by someone lacking a gallbladder, can lead to pancreatitis – or inflammation … [Read more...]
California Court Denies Opioid Manufacturer Access to Insurance Coverage
A decision in a California appeals court could have implications for the future of opioid litigation and the liability of Big Pharma in the opioid crisis. After Travelers Property Casualty, an insurance company for Watson Pharmaceuticals, submitted a … [Read more...]
A Breakdown of the Stockert 3T Infection
When nontuberculous mycobacterium (NTM) infections started to appear in patients who had undergone open-heart surgery and other similar procedures, the FDA thought it was related to heater-cooler systems generally – not any one type in particular. … [Read more...]